CD86 and neoplasm: In a recent study, a comparable CRISPRa technique was utilized to simultaneously activate multiple endogenous genes such as Cd70, Cd80, Cd86, Ifnα4, Ifnβ1, and Ifnγ, triggering anti-tumor adaptive immune clearance of tumor cells in a mouse model [151].